RESEARCH TRIANGLE PARK, NC – The Burroughs Wellcome Fund is pleased to announce the inaugural class of the Innovation in Regulatory Science Award. The award provides up to $500,000 over five years to academic investigators who are addressing research questions that will lead to innovation in regulatory science, with ultimate translation of those results into improving the regulatory process.
Food and Drug Administration defines regulatory science as the “development and use of new tools, standards, and approaches to more efficiently develop products and to more effectively evaluate product safety, efficacy, and quality”. It is has become the centerpiece of the FDA’s strategy to foster innovation and the agency has called on the academic and foundation communities to take an active role in building this emerging field.
This initiative of the Burroughs Wellcome Fund is focused on providing support for academic researchers developing new methodologies or innovative approaches in regulatory science that will ultimately inform regulatory decisions.
“Regulatory science is not a high profile research area,” said BWF President Dr. John Burris. “But the results have the potential to make an enormous impact”.
The 2013 recipients of the Innovation in Regulatory Science Award are:
Dana V. Devine, Ph.D.
Canadian Blood Services
Refreshing the regulatory approach to ensuring the safety and efficacy of blood transfusion products
Kathleen M. Giacomini, Ph.D.
University of California-San Francisco
Systems pharmacology approaches to understanding drug-induced weight gain
Alison H. Harrill, Ph.D.
University of Arkansas for Medical Sciences
Advancing regulatory science through translational pharmacogenomics
Calum A. MacRae, M.B. Ch.B., Ph.D.
Brigham and Women’s Hospital/Harvard Medical School
Building structure-related prediction algorithms for organ-specific drug toxicity through iterative modeling in novel zebrafish reporter lines
Vishal S. Vaidya, Ph.D.
Brigham and Women’s Hospital
Mapping the biology of a damaged kidney cell
Susan W. Yackee, Ph.D.
University of Wisconsin-Madison
When politics intrudes on science: regulatory policymaking at the FDA